Live sport can be challenging for neurodivergent fans. Here’s what support is available at the Women’s World Cup

Erin Mitchell loves football but hasn’t gone to a game in years.

“It’s always been part of our family, my brothers played, and then I played,” she says.

“You want to be there because you love the vibe and the environment, but there’s also that constant anxiety.”

Based on the Central Coast of New South Wales, Mitchell once held a Mariners season pass but stopped attending matches due to the sensory challenges caused by her autism and ADHD.

“As my kids got slightly older, they became more sensitive to noise and so did I,” Mitchell says.

“I became a lot more sensitive to the people and the stress of all the sensory inputs… but I still enjoy watching TV.”

Mitchell gets anxious in large crowds. (ABC News: Emma Simkin)

Attending live games is often challenging for neurodivergent people, including those with autism, dementia, attention-deficit/hyperactivity disorder (ADHD), or post-traumatic stress disorder (PTSD).

Mitchell describes it as an oppressive feeling.

“I always felt on the edge, like I could never fully relax at a game,” she says.

“My anxiety presents in anger, so I used to get very angry at people around me for making too much noise. That bothered me, but I couldn’t help it.”

Tasks that seem mundane to most of the population can be stressful for neurodivergent people, like lining up for toilets, food, drinks, or to enter and exit the venue.

Filling up the stress ‘bucket’

Autistic people often experience the world from the bottom up, taking in all the information from the surrounding environment, unable to filter out unnecessary details in the way neurotypical people can.

Source link

#Live #sport #challenging #neurodivergent #fans #Heres #support #Womens #World #Cup

Multimillionaire Psychologist Wins Bid To Repurchase Her Bankrupt Chain Of Autism Therapy Centers

The Center for Autism and Related Disorders was worth $600 million when Doreen Granpeesheh sold it to Blackstone in 2016 for a big payout. On Wednesday, she received court approval to repurchase the now-bankrupt firm for less than $50 million—and has nascent plans to “turn it around.”


Doreen Granpeesheh was on vacation in Costa Rica with her family when she heard the news that she won her bid to repurchase the Center for Autism and Related Disorders, a chain of autism therapy clinics she founded in 1990, grew into a national chain and sold to private equity giant Blackstone five years ago. She’d flown from Manhattan, where the auction was held in-person, to the Central American country for a pre-planned trip on July 20, the fourth day of a five-day auction—she didn’t realize the auction would stretch as long as it did—and finished the bidding process remotely last week.

On Wednesday afternoon, Granpeesheh’s winning bid—a $48.5 million cash package that included over $25 million of her own money, $10 million from former CARD managing director Sangam Pant and $11 million from private equity firm Audax, according to Granpeesheh—received bankruptcy court approval. That purchase price is double the initial bid from Granpeesheh and Pant of $25 million but far less than the $300 million payout Granpeesheh had received when selling CARD to Blackstone five years ago.

“It was such a relief, I was shaking and crying and laughing out loud, you know, like, really like laughing as if I’ve seen a comedy scene or something, and feeling so emotional,” Granpeesheh says.

Granpeesheh, age 60, stepped down as CARD’s CEO in 2019, after nearly 30 years at the company’s helm, and left the board in 2022 because 40 years dedicated to one field is “long enough,” she wrote in January. But that was before CARD filed for bankruptcy in June, and things have, clearly, changed.

Her winning bid beat out two other bidders, both from private equity firms with investments in autism treatment organizations: Audax and Lorient. A couple of days into the auction, Granpeesheh and Pant ended up partnering with the smaller of the two entities, Audax, which owns treatment centers and schools mostly in Virginia that operate under the names Your Life ABA and Proud Moments ABA—in hopes of outbidding Lorient and its autism therapy firm Behavior Frontiers.

Granpeesheh, who is one of America’s richest self-made women, is worth an estimated $350 million, thanks to CARD’s sale to Blackstone. Using some of those proceeds, Granpeesheh raised her part of the bid from $15 to $27 million in what she called a“frustrating” process that ran from 9 a.m. to nearly 9 p.m. each day for five days and included bidders’ need to up their offers on numerous occasions. Lorient ended up as the backup bid, which will go into effect if Pantogran—the partnership between Granpeesheh and Pant—and Audax can’t come up with the $48.5 million in funds. (Initially Livingstone, CARD’s investment banker, contacted 84 potentially interested entities after the company’s Chapter 11 petition.)

Court filings say CARD will keep all of its 130 centers open after the sale, although Granpeesheh says 18 of the centers, including all Virginia centers, as well as clinics in New York, New Jersey and Nevada, will go to the Audax-affiliated entities, which will split off from CARD. That will leave CARD with 112 centers, down from its 2018 peak of 265 clinics, and likely treating less than half the 7,000 patients it saw five years back.

In the last couple of years, CARD has struggled due to the pandemic, higher labor costs, changes in insurance payout policies, staffing shortages and, according to four former employees, a model that put profits ahead of patient care—which ultimately led to the company’s June 11 bankruptcy filing. Now, even with $18 million in loans to carry it through bankruptcy proceedings, CARD projects it will run out of cash by August and will need additional funding. In the 12 months through April 2023, CARD posted revenues of at least $160 million but lost $82 million. Granpeesheh says she’s willing to put up additional personal funds, much of which came from CARD’s 2018 sale, to keep the company going.

Chapter 11 bankruptcy cases usually take several months or even years. Throughout the process thus far, representatives of CARD and U.S. bankruptcy judge David Jones stressed the urgency of CARD’s bankruptcy case. Court declarations and transcripts repeatedly cited CARD’s low cash reserves ($2 million when it filed for bankruptcy on June 11) and that the company is an important and sensitive asset, since CARD centers the medical treatment of young children.

“Not only does [CARD] provide jobs and fill a spot in the market, it also provides a very valuable service to a segment of our population that needs help,” Jones said in Wednesday’s hearing. He also said he was pleased with how quickly and smoothly proceedings have gone so far and expressed surprise that the auction had managed to double CARD’s original sale price.

Granpeesheh knows that getting CARD to break even again won’t be easy and has plans to help the company “be lean.”

Between now and when she takes over again on August 25, Granpeesheh and Pant say they will interview the approximately 200 corporate employees to decide “who’s staying with us,” she says, while stressing that she plans to keep all clinic-based staff. They will also review all of CARD’s vendor contracts and decide which to keep, hoping to “reduce expenses as much as possible.”

Additionally, Granpeesheh believes she’ll be able to help the company by increasing morale and cultivating employees’ sense of ownership in the company, although she doesn’t exactly know what that will look like yet.

She plans to spend the next year flying around the country to visit every CARD location in person and talk to employees about what challenges they’re facing. Additionally, she plans to reinstate the weekly “CEO call” she used to hold, where anyone in the company can join and ask questions—although she stresses she doesn’t yet know what her title will be this time around: “I just want to talk to people, listen and explain things.”

Granpeesheh still wants to open new CARD clinics, eventually, but she acknowledges that she can’t rush to grow this time around like she did in the past. “It’s a matter of getting to know the newest generation of CARD workers and not putting too much pressure on growing fast.”

Through all of this, and in addition to CARD’s lack of funds, Granpeesheh will continue to face industry-wide struggles in recruiting and retaining therapists and have to keep responding to criticism that the type of intense therapy CARD deploys—which reinforces certain behaviors and tries to eliminate others—can make some kids feel miserable and can correlate with lower self-image when they’re adults. Granpeesheh, for her part, says it’s “sad to hear there are still so many critics.”

Still, Granpeesheh remains hopeful, even while acknowledging that it’ll be an uphill battle.

“It doesn’t feel like a challenge, because I built it,” she says. “It doesn’t feel scary, it feels exciting.”

Source link

#Multimillionaire #Psychologist #Wins #Bid #Repurchase #Bankrupt #Chain #Autism #Therapy #Centers

RFK Jr. And Elon Musk: Two Great Dicks That Taste Like Sh*t!

Robert F. Kennedy Jr. sure has come a long way from 2014, when he angered fossil fuel lobbyists by saying that climate change deniers should be jailed. Or maybe not such a long way; by 2005 he was already spreading the anti-vax gospel and falsely claiming that childhood vaccines cause autism. And now he’s running for president and everyone is reminding you what a complete freakass whackaloon he is.

We’ll do our part. Hey, remember that long-ago time in 2022 when he said, of COVID vaccine mandates, that at least in Nazi Germany “you could cross the Alps into Switzerland, you could hide in an attic like Anne Frank did.”

Kennedy did his part to help out that educational endeavor Monday night by sitting down with chief Twitter troll Elon Musk, who seems to love conspiratorial bullshit nearly as much as Kennedy does. He started out by thanking Musk for ending all the terrible “censorship” on the platform — by making it a free-for all for COVID and vaccine disinformation, not to mention for Nazis, far-Right conspiracy theories, and rampant hatred of transgender people, but also by actually censoring people on behalf of authoritarian governments. Kennedy also explained that in 2021, “the government pressured Mark Zuckerberg” to ban him from Instagram, although now his account has been restored because he’s running for president. Talk about ineffective censorship!


Rolling Stone reports that for the first 40 minutes of the Twitter Spaces chat, Kennedy barely talked about his candidacy, because he and Musk were too busy telling each other how much they admired each other for being courageous and shit, which is honestly what free speech is for.

At one point, Kennedy asked where Musk got the courage to be like one of America’s Founders by being “willing to take this huge, massive, unspeakable economic hit on behalf of a principle for a country in which you weren’t even born?” Musk, who does kind of have US citizenship after all, replied, “I should say I do very much consider myself an American.” Musk also acknowledged that advertisers had deserted the platform because he was so very committed to democracy, at least for people who think he’s cool, so it’s been “frankly a struggle to break even” (he is not breaking even) and then everyone with an $8 blue checkmark felt very warm that they had done their part to save America and/or Twitter.

After they both agreed that free speech is the very best, and that they both really love free speech the most, Kennedy bemoaned the sad fact that “we’re no longer living in a democratic system,” because Big Pharma controls the government and silences brave advocates of medical disinformation, which would explain why we only hear from anti-vaxxers everywhere on social media but not yet in (most) doctors’ offices.

Among other great trolls, Musk and Kennedy were joined by Tulsi Gabbard and Michael Shellenberger, author of books about how environmentalism is bad for everyone and global warming is happening but is honestly no big deal, yeesh, calm down. UPDATE/CORRECTION: I initially had a brain fart and confused Shellenberger with a different “contrarian” dipshit, Alex Berenson, formerly of the New York Times. Wonkette regrets the error.

Kennedy and Musk agreed that America shouldn’t be supporting the Ukrainian government, since as Kennedy put it, the Ukrainian people are “almost equally” victimized by America as by Russians. Musk added that the war was kind of our fault anyway, since “We are sending the flower of Ukrainian youth and Russian youth to die in the trenches, and it’s morally reprehensible,” and when you think about it, we probably shouldn’t be ordering Russia’s youth flowers around like that, how would we like it huh?

The conversation got even more sane when Gabbard added that

the U.S. had turned Ukraine into a “slaughterhouse” and blamed the conflict on an “elitist cabal of war-mongers” who had seized control of the Democratic Party.

Those war-mongers, Kennedy warned, hadn’t just taken control of the Democratic party: They were in control of the Deep State as well.

He recalled being told by Donald Trump’s former CIA Director Mike Pompeo that the “top layer of that agency is made up almost entirely of people who do not believe in the American institutions of democracy,” which is pretty rich coming from a top guy in the Trump administration.

Kennedy also said he opposed an assault weapons ban, because the Second Amendment is pretty awesome, and anyway, the problem isn’t guns, it’s antidepressant meds, which turn people into mass shooters, explaining that

“prior to the introduction of Prozac, we had almost none of these events in our country. […] The one thing that we have, it’s different than anybody in the world, is the amount of psychiatric drugs our children are taking.” He then alleged that the National Institutes of Health won’t research the supposed link between these drugs and shootings “because they’re working with the pharmaceutical industry.”

It’s pretty convincing until you remember that antidepressants are prescribed worldwide, but in countries where there aren’t more guns than people, there aren’t a bunch of school shootings. Also, maybe someone could have pointed out that only about a quarter of mass shooters use antidepressants, while 100 percent of them use firearms, albeit not usually with a doctor’s prescription.

Along the way, Kennedy also insisted that COVID was a “bioweapon,” lied that after the passage of the Affordable Care Act the “Democrats were getting more money from pharma than Republicans” (it’s the other way around, according to STAT News, but then STAT News believes vaccines work), and promised to go to the US-Mexico border to “try to formulate policies that will seal the border permanently,” so he really sounds like the mainstream Democrat that everyone on the far Right has been looking for, the end and OPEN THREAD.

[Rolling Stone / Insider / NYT]

Yr Wonkette is funded entirely by reader donations. If you can, please give $5 or $10 a month so we can keep this little mommyblog going!

Do your Amazon shopping through this link, because reasons.



Source link

#RFK #Elon #Musk #Great #Dicks #Taste #Sht

Autism Fast Facts | CNN



CNN
 — 

Here is a look at autism.

Autism or autism spectrum disorder (ASD) incorporates a group of neurodevelopmental disorders causing impaired communication skills and social skills. ASD generally starts before three years of age and lasts a lifetime, but early intervention plays a role in treatment and progress.

ASD is about four times more common among boys than girls, according to the Centers for Disease Control and Prevention (CDC).

ASD can be found among all races, ethnicities and socioeconomic groups.

The prevalence of ASD in the United States is about one in 36 8-year-olds, according to a 2023 CDC report.

Health care costs for children with autism are four to six times greater than medical costs for children without autism, according to research published in the Journal of Autism and Developmental Disorders.

April 2 is World Autism Day.

There is no definitive medical test to diagnose autism. Instead, the disorder is diagnosed by observing a child’s development.

According to the CDC, signs of autism may include deficits in social communication and interaction in a variety of contexts, difficulty engaging in back-and-forth conversation and an absence of interest in forming friendships with peers.

The debate over whether autism spectrum disorders are caused by vaccines started in 1998 when the medical journal The Lancet published a now-retracted study by researcher Andrew Wakefield linking the MMR vaccine to autism.

Most of Wakefield’s co-authors withdrew their names from the study when they learned he had been compensated by a law firm intending to sue manufacturers of the vaccine in question. In 2010, Wakefield lost his medical license. In 2011, the Lancet retracted the study after an investigation found Wakefield altered or misrepresented information on the 12 children who were the basis for the conclusion of the study.

Other researchers have not been able to replicate Wakefield’s findings. Several subsequent studies trying to reproduce the results have found no link between vaccines and autism, including several reviews by the Institute of Medicine.

Early 1900s – Autistic characteristics are studied as symptoms of schizophrenia.

1938 – Donald Gray Triplett of Mississippi is first examined by child psychiatrist Leo Kanner of Johns Hopkins Hospital and later becomes the first person diagnosed with autism symptoms.

1943 – Triplett is identified as “Donald T.” in the paper “Autistic Disturbances of Affective Contact” by Kanner. The paper elaborates on the idea that autism is related to lack of parental warmth; this is later dubbed the “refrigerator mother” theory.

1944 – Hans Asperger, an Austrian physician, publishes a paper about autistic syndrome. The paper gains wider recognition when it is translated into English in the early 1990s.

1964 – Bernard Rimland, a research psychologist, publishes “Infantile Autism: The Syndrome and Its Implications for a Neural Theory of Behavior,” which contradicts the “refrigerator mother” hypothesis. Kanner is the author of the foreword.

1965 – Rimland founds the National Society for Autistic Children (now the Autism Society). He later establishes the Autism Research Institute.

1980 – Autism is classified separately from schizophrenia in the third edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-III).

December 18, 2007 – The United Nations adopts a resolution declaring April 2 World Autism Awareness Day.

October 29, 2014 – The medical journal Nature reports that scientists have identified 60 genes with a greater than 90% chance of increasing a child’s autism risk.

December 17, 2015 – Scientists at Harvard and MIT announce they have found, for the first time, a link between autistic behavior and reduced activity of a key neurotransmitter, a type of brain chemical that enables the transmission of signals across neurons, allowing the brain to communicate with other organs.

April 21, 2016 – The Simons Foundation announces that it is launching an autism research project called SPARK. The study, which involves scientists at 21 hospitals and university clinics, will focus on the possible connection between genetics and autism. Parents of children with autism are invited to sign up online and participate in the study. The group also works with Autism Speaks and the Autism Science Foundation to run the Autism BrainNet network, which is an autism brain bank that collects postmortem donations.

February 2017 – Researchers find that monitoring MRI brain scans of infants may help predict whether they will develop autism, according to a study published in the journal, Nature. The researchers found a possible link between brain enlargement during the first year of life and an autism diagnosis at age 2. This builds on previous similar research.

March 19, 2017 – CBS News’ “60 Minutes” profiles “Sesame Street’s” newest Muppet character, a girl named Julia who has autism.

April 11, 2017 – A study published in the American Journal of Public Health finds that people with autism are three times more likely than the general population to die because of preventable injuries, and children and young teens with autism are 40 times more likely to die from preventable injury than the general child population. Suffocation, asphyxiation and drowning are the leading causes of fatal injuries among people with autism.

March 26, 2018 – According to a study published in JAMA Pediatrics, children with autism spectrum disorder and their younger siblings are less likely to be fully vaccinated than children unaffected by autism.

March 4, 2019 – A study of over 650,000 children published in the journal Annals of Internal Medicine shows that the measles, mumps, and rubella vaccine does not increase the risk of autism and does not trigger autism in children who are at risk.

April 29, 2019 – A study published in JAMA Pediatrics suggests that children can be screened for autism spectrum disorder at 14 months of age with high accuracy (instead of 18 to 24 months of age, as is currently recommended).

January 23, 2020 – A study in the journal Cell identifies 102 genes that are associated with an autism risk. Previously, researchers were only aware of 65.

May 10, 2020 – In a report published in the Journal of Autism and Developmental Disorders, the CDC estimates that 2.2% of Americans adults have autism spectrum disorder. The report, which is the first US study of autism in adults, indicates that up to 5.4 million people age 18 and older, or about 1 in 45 people, have an autism spectrum condition.

February 14, 2022 – A meta-analysis published in JAMA Pediatrics finds that early mortality, due to natural or unnatural causes, is more than two times more likely for people with autism spectrum disorder than the general population.

Source link

#Autism #Fast #Facts #CNN

Vaccines Fast Facts | CNN



CNN
 — 

Here’s a look at information and statistics concerning vaccines in the United States. For vaccines related to coronavirus, see Coronavirus Outbreak Timeline Fast Facts.

The Centers for Disease Control and Prevention (CDC) provides vaccine recommendations by age, as well as by disease.

For more than 100 years, there has been public discord regarding vaccines based on issues like individual rights, religious freedoms, distrust of government and the effects that vaccines may have on the health of children.

Exemptions to vaccines fall into three general categories: medical, religious and philosophical.

As of May 25, 2022, 44 states and the District of Columbia have enacted legislation allowing religious exemptions from vaccines, and 15 states allow philosophical (non-spiritual) exemptions.

1796 – Edward Jenner develops the smallpox vaccine, the world’s first successful vaccine.

1855 – Massachusetts mandates that school children are to be vaccinated (only the smallpox vaccine is available at the time).

February 20, 1905 – In Jacobson v. Massachusetts, the US Supreme Court upholds the State’s right to compel immunizing against smallpox.

November 13, 1922 – The US Supreme Court denies any constitutional violation in Zucht v. King in which Rosalyn Zucht believes that requiring vaccines violates her right to liberty without due process. The High Court opines that city ordinances that require vaccinations for children to attend school are a “discretion required for the protection of the public health.”

1952 – Dr. Jonas Salk and his team develop a vaccine for polio. A nationwide trial leads to the vaccine being declared in 1955 to be safe and effective.

1963 – The first measles vaccine is released. In 2000, the CDC declares the US has achieved measles elimination, defined as “the absence of continuous disease transmission for 12 months or more in a specific geographic area.” While the US has maintained measles elimination since, there are occasional outbreaks.

1986 – Congress passes the National Childhood Vaccine Injury Act. This coordinates vaccine activities across several government agencies to monitor vaccine safety, requires vaccine information statements are provided to those receiving vaccines, and creates the National Vaccine Injury Compensation Program to compensate those injured by vaccines on a “no fault” basis.

March 19, 1992 – Rolling Stone publishes an article by Tom Curtis, “The Origin of AIDS,” which presents a theory that ties HIV/AIDS to polio vaccines. Curtis writes that in the late 1950s, during a vaccination campaign in Africa, at least 325,000 people were immunized with a contaminated polio vaccine. The article alleges that the vaccine may have been contaminated with a monkey virus and is the cause of the human immunodeficiency virus, later known as HIV/AIDS.

August 10, 1993 – Congress passes the Omnibus Budget Reconciliation Act which creates the Vaccines for Children Program, providing qualified children free vaccines.

December 9, 1993 – Rolling Stone publishes an update to the Curtis article, clarifying that his theory was not fact, and Rolling Stone did not mean to suggest there was any scientific proof to support it, and the magazine regrets any damage caused by the article.

1998 – British researcher Andrew Wakefield and 12 other authors publish a paper stating they had evidence that linked the vaccination for Measles, Mumps and Rubella (MMR) to autism. They claim they discovered the measles virus in the digestive systems of autistic children who were given the measles, mumps and rubella (MMR) vaccine. The publication leads to a widespread increase in the number of parents choosing not to vaccinate their children for fear of its link to autism.

2004 – Co-authors of the Wakefield study begin removing their names from the article when they discover Wakefield had been paid by lawyers representing parents who planned to sue vaccine manufacturers.

May 14, 2004 – The Institute of Medicine releases a report “rejecting a causal relationship between the MMR vaccine and autism.”

February 2010 – The Lancet, the British medical journal that published Wakefield’s study, officially retracts the article. Britain also revokes Wakefield’s medical license.

2011 – Investigative reporter Brian Deer writes a series of articles in the BMJ exposing Wakefield’s fraud. The articles state that he used distorted data and falsified medical histories of children that may have led to an unfounded relationship between vaccines and the development of autism.

2011 – The US Public Health Service finds that 63% of parents who refuse and delay vaccines do so for fear their children could have serious side effects.

June 17, 2014 – After analyzing 10 studies, all of which looked at whether there was a link between vaccines and autism and involved a total of over one million children, the University of Sydney publishes a report saying there is no correlation between vaccinations and the development of autism.

February 2015 – Advocacy group Autism Speaks releases a statement, “Over the last two decades, extensive research has asked whether there is any link between childhood vaccinations and autism. The results of this research are clear: Vaccines do not cause autism. We urge that all children be fully vaccinated.

August 23, 2018 – A study published in the American Journal of Public Health finds that Twitter accounts run by automated bots and Russian trolls masqueraded as legitimate users engaging in online vaccine debates. The bots and trolls posted a variety of anti-, pro- and neutral tweets and directly confronted vaccine skeptics, which “legitimize” the vaccine debate, according to the researchers.

October 11, 2018 – Two reports published by the CDC find that vaccine exemption rates and the percentage of unvaccinated children are on the rise.

January 2019 – The World Health Organization names vaccine hesitancy as one of 10 threats to global health in 2019.

September 4, 2019 – Facebook announces that educational pop-up windows will appear on the social media platforms when a user searches for vaccine-related content, visits vaccine-related Facebook groups and pages, or taps a vaccine-related hashtag on Instagram

December 19, 2019 – The US Food and Drug administration announces the approval of a vaccine for the prevention of the Ebola virus for the first time in the United States. The vaccine, Ervebo, was developed by Merck and protects against Ebola virus disease caused by Zaire ebolavirus in people 18 and older.

December 27, 2019 – A study published in the medical journal JAMA Network Open finds that a single dose of the human papillomavirus (HPV) vaccine may be just as effective as two or three doses at preventing cancer-causing HPV infection.

February 3, 2020 – The National Institute of Allergy and Infectious Diseases (NIAID) announces that a clinical trial for an HIV vaccine has been discontinued since the vaccine was not found to prevent infections of human immunodeficiency virus, the virus that causes AIDS.

May 3, 2023 – The US FDA approves, Arexvy, the first vaccine to protect against respiratory syncytial virus or RSV. It is a single shot for adults 60 or older.

Source link

#Vaccines #Fast #Facts #CNN

What is autism? An expert explains | CNN



CNN
 — 

Some individuals with autism have challenges processing senses. Others struggle to communicate. Still others might have a tough time socializing, thinking, physically moving or just going about daily living.

People with autism have their own ways of interacting with the world, because autism is a developmental disability that affects everyone who has it a little differently, according to Dr. Daniel Geschwind, the Gordon and Virginia Macdonald distinguished professor of human genetics, neurology and psychiatry at UCLA.

Geschwind has spent 25 years studying autism and what causes it. To mark Autism Awareness Month, CNN talked with him about what autism is and what causes it.

This conversation has been lightly edited and condensed for clarity.

CNN: What is autism?

Dr. Daniel Geschwind: Autism refers to a broad range of conditions characterized by challenges with social skills and social and communication and repetitive behaviors, resistance to changes in routine, or restricted interests. I prefer to call it “the Autisms,” because it’s not one thing, and no two autistic children or adults are exactly alike even though they may share basic features. People with autism may also have some sensory-motor integration issues, especially sensory hypersensitivity.

CNN: How prevalent is autism today?

Geschwind: It isn’t rare. The most recent statistics (from the US Centers for Disease Control and Prevention) came out in March, pulled data from 11 sites (in the United States) and reported 1 out of every 36 kids is autistic. The study before that estimated around 1 in 40. About 10 years ago, the autism rate was 1 in 100, or even lower.

It would be easy to look at this trend and say autism is increasing, but that’s not really what is happening. The most recent data reflects that our ability to recognize autism and diagnose it early has improved dramatically. We’re now able to diagnose people with autism who might have (previously) fallen through the cracks.

Everybody is neurodivergent to some extent. For example, if you look at a simple IQ test, a substantial portion of people will perform really badly on one specific item. That doesn’t mean they have problems — it’s just that it means we all have strengths and weaknesses.

If I were being tested on artistic ability, for example, or engineering ability, I would be far below what’s called typical. I think we have to accept that intelligence is not just one thing, that cognition isn’t one thing, that there’s not just one way to behave.

CNN: What does it mean when people describe some as being “on the spectrum”?

Geschwind: About a decade ago, the term “autism spectrum disorder” was adopted to encompass everything that we called autism into one rubric. The intent was simply to describe the variability in how people with autism act and behave biomedically. There are some autistic individuals who just need accommodations and don’t need treatment. There are other autistic individuals who need a lot of treatment. The spectrum was intended to include them all.

Over time, non-autistic people began referring to the spectrum in a linear fashion: high to low. That means some autistic individuals were categorized as “high-functioning,” while others were categorized as “low-functioning.” For many, the notion of a spectrum is now a loaded term. Many believe that instead of talking about autism in a linear fashion, we should talk about it as a wheel or pie, where each slice represents a different trait and every individual has different strengths and weaknesses.

CNN: Is there a cure for autism?

Geschwind: There is no cure. At the same time, we’ve come very far in understanding what autism is, and we’re making progress on how to treat it. When I started researching autism 25 years ago, the autism rate was 1 in 1,000 or 1 in 2,000. To put it in deeper historical perspective, I think at that time there was only about $10 million a year or less in autism research being done that was funded (by the National Institutes of Health). And so, there was a huge disconnect between the research dollars, public awareness and the real needs of patients and families.

The notion of the term “curing” autism can be controversial. From my perspective, our true goal is to establish a kind of personalized medicine, or precision health in autism and other neuropsychiatric disorders, so that each autistic person is seen as the individual they are. We envision a world where individuals who are severely impacted by autism have the opportunity to get therapy and drugs that can help them — and those for whom a therapy is not warranted or who don’t want it will have opportunities to live life the way they want to as well. Patient autonomy and societal accommodation are important aspects when considering these issues.

CNN: What causes autism?

Geschwind: Almost every medical condition has both genetic and environmental components. In autism, it seems that heritability is very high. The most recent large study suggested that heritable genetic factors — the things that you get from your parents that your parents have in their DNA — are probably somewhere around 80% or slightly higher.

That leaves 20% that’s nonheritable, and of that we know that at least 10% of autism is caused by rare mutations that are not inherited. And that sounds like a paradox, but it’s not. If you think about Down syndrome, that’s a genetic mutation that the parents don’t have in their DNA. That’s called a new, or de novo, mutation.

You can calculate a risk score for having autism based on genetics, (but) right now, the risk score for autism is not that predictive because we haven’t done enough research. For other conditions like cardiovascular or certain cancers, risk scores are very predictive because very large numbers of people have been studied.

Even so, this autism risk score is strongly correlated with high educational attainment, or a high IQ, which again speaks to the strengths associated with being autistic and highlights that we need to be more aware of the strengths that autistic individuals may have as well to optimize their opportunities to achieve their goals or contribute to society.

There also are several environmental factors that have been shown to increase the risk of autism. One of them is maternal exposure to valproate, which is an anti-epilepsy medication. There are several maternal viral infections that have been associated with autism. And two other things: the interbirth interval — how quickly after one birth a mother has another — and the age of the father. The thought on the last point is that as a man ages, their DNA repair mechanisms are maybe less active, and there are more frequent mutations in sperm.

A key point is that all these known environmental factors act prenatally, so in most cases the tendency towards being on the spectrum is something that individuals are born with.

CNN: To what extent has research debunked the controversial notion that vaccines can cause autism?

Geschwind: The notion that vaccines cause autism has been entirely (disproved). There have been dozens of studies, using very different methodologies. There is absolutely no evidence that vaccines cause autism, and there’s been much more harm than good done by purveyors of that fiction.

CNN: How do you treat autism?

Geschwind: It is imperative to have an early diagnosis, because we know that early identification and early intervention with behavioral therapies can be effective in up to 50% of kids. Some kids will respond so well that it’s very hard to make a diagnosis of autism when they’re 9 years old if the therapy is started early enough.

The problem is that for many autistic individuals, current therapies are not that effective. There’s a lot of work being done developing more effective cognitive behavioral therapies, figuring out which therapy is the best for which child. There’s also work being done to develop medications that can be helpful to treat certain symptoms such as injurious behavior, repetitive behavior or difficulty with changes in routines.

My colleagues and I want to use treatment to augment and improve people’s symptoms, not change who they are fundamentally. We believe strongly in every individual’s autonomy. We also believe in personalized medicine so that it’s not one-size-fits-all. There will be some patients in whom we’re trying to correct a severe genetic mutation that has profound consequences, and there’ll be others that need only a handful of accommodations, just like we provide for folks who need wheelchairs.

CNN: What will your research focus on next?

Geschwind: There are two basic frontiers in my research. One recognizes that most of the work in neuropsychiatric disorders and autism has been done in primarily White European populations and focuses on a pressing need to be studying diverse populations. About seven or eight years ago, I started working with African American communities because certain aspects of genetics are population-specific, and we as researchers really need to understand that.

The frontier that is crosscutting across all of this is we need to be able to move from genetics in a population to genetics in an individual, so that by looking at somebody’s genetic makeup, we can understand the mechanism of their autism. This is precision medicine.

My work is trying to understand how specific genetic variants, how specific mutations, impact brain development to eventually lead to the symptoms of autism. If my colleagues and I can understand that mechanism, just like we can understand the genetic mechanism in cancer, we can find a drug to target that and improve those symptoms over time.

Source link

#autism #expert #explains #CNN